Engineered Stem Cell-Derived Exosomes for Precision Regenerative Medicine: Molecular Targeting, Cargo Optimization, and Therapeutic Applications
Abstract
Regenerative medicine has increasingly transitioned from cell-based therapies to cell-free approaches due to the constraints of stem cell transplantation, such as limited engraftment efficiency, immunogenicity, tumorigenic potential, and difficulties in clinical standards. Among novel cell-free methodologies, stem cell-derived exosomes have garnered considerable interest as nanoscale extracellular vesicles that facilitate tissue repair via paracrine signaling. Recent advancements in molecular biology and bioengineering have facilitated the creation of modified exosomes, permitting precise alterations of surface molecules and bioactive cargo to improve therapeutic specificity and efficacy. This narrative review encapsulates current advancements in synthetic stem cell-derived exosomes for precision regenerative medicine, emphasizing molecular targeting techniques, therapeutic cargo optimization, and applicability across various disease types. Literature pertinent to the years 2020 to 2025 was sourced from PubMed, Scopus, and ScienceDirect and subjected to qualitative analysis. The results demonstrate that modified exosomes can efficiently regulate critical biological pathways associated with apoptosis, inflammation, angiogenesis, and tissue regeneration. Improved targeting specificity increases tissue accumulation and therapeutic efficacy, while tailored cargo allows for precise modulation of molecular signaling in damaged microenvironments. Despite encouraging preclinical results, challenges related to production standardization, cargo uniformity, dosage optimization, and long-term safety hinder clinical translation. However, ongoing advancements in bioengineering, nanotechnology, and regulatory structures position modified exosomes as strong contenders for the development of next-generation regenerative therapeutics. Engineered stem cell-derived exosomes are a versatile and unique platform with considerable promise to connect molecular mechanisms and clinical applications in precision regenerative medicine.
References
Lee JY, Kim HS. Extracellular Vesicles in Regenerative Medicine: Potentials and Challenges. Tissue Eng Regen Med. 2021;18(4):479-484. doi:10.1007/s13770-021-00365-w
Petrus-Reurer S, Romano M, Howlett S, Jones JL, Lombardi G, Saeb-Parsy K. Immunological considerations and challenges for regenerative cellular therapies. Commun Biol. 2021;4(1):798. doi:10.1038/s42003-021-02237-4
Hussen BM, Taheri M, Yashooa RK, et al. Revolutionizing medicine: recent developments and future prospects in stem-cell therapy. Int J Surg. 2024;110(12):8002-8024. doi:10.1097/JS9.0000000000002109
Chang SH, Park CG. Comparing the Benefits and Drawbacks of Stem Cell Therapy Based on the Cell Origin or Manipulation Process: Addressing Immunogenicity. Immune Netw. 2023;23(6). doi:10.4110/in.2023.23.e44
Xu Y, Song Y, Zhang C, et al. Mesenchymal stem cells-derived miR-143–3p attenuate acute kidney injury by suppressing TAK1-Driven necroptosis. Biochem Biophys Res Commun. 2025;778:152339. doi:10.1016/j.bbrc.2025.152339
Wong RSY, Tan EW, Goh BH. Mesenchymal Stem Cell-Based Therapies: Challenges and Enhancement Strategies. Cell Biochem Biophys. Published online September 26, 2025. doi:10.1007/s12013-025-01895-z
Deng S, Cao H, Cui X, Fan Y, Wang Q, Zhang X. Optimization of exosome-based cell-free strategies to enhance endogenous cell functions in tissue regeneration. Acta Biomater. 2023;171:68-84. doi:10.1016/j.actbio.2023.09.023
Chou Y, Alfarafisa N, Ikezawa M, Khairani A. Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging. Clin Cosmet Investig Dermatol. 2023;Volume 16:3383-3406. doi:10.2147/CCID.S434439
Gwam C, Mohammed N, Ma X. Stem cell secretome, regeneration, and clinical translation: a narrative review. Ann Transl Med. 2021;9(1):70-70. doi:10.21037/atm-20-5030
Trigo CM, Rodrigues JS, Camões SP, Solá S, Miranda JP. Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? J Adv Res. 2025;70:103-124. doi:10.1016/j.jare.2024.05.004
Kalluri R, LeBleu VS. The biology , function , and biomedical applications of exosomes. Science (80- ). 2020;367(6478). doi:10.1126/science.aau6977
Chen YF, Luh F, Ho YS, Yen Y. Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials. J Biomed Sci. 2024;31(1):67. doi:10.1186/s12929-024-01055-0
Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9(1):17. doi:10.1038/s41392-023-01704-0
Thakur A, Shah D, Rai D, et al. Therapeutic Values of Exosomes in Cosmetics, Skin Care, Tissue Regeneration, and Dermatological Diseases. Cosmetics. 2023;10(2):65. doi:10.3390/cosmetics10020065
Roszkowski S. Therapeutic potential of mesenchymal stem cell-derived exosomes for regenerative medicine applications. Clin Exp Med. 2024;24(1):46. doi:10.1007/s10238-023-01282-z
Jo C, Choi YJ, Lee TJ. Therapeutic Potential of Stem Cell-Derived Exosomes in Skin Wound Healing. Biomimetics. 2025;10(8):546. doi:10.3390/biomimetics10080546
Huang D, Shen H, Xie F, et al. Role of mesenchymal stem cell-derived exosomes in the regeneration of different tissues. J Biol Eng. 2024;18(1):36. doi:10.1186/s13036-024-00431-6
Bahadorani M, Nasiri M, Dellinger K, Aravamudhan S, Zadegan R. Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies. Int J Nanomedicine. 2024;Volume 19:7137-7164. doi:10.2147/IJN.S464249
Li L, Wang F, Zhu D, Hu S, Cheng K, Li Z. Engineering exosomes and exosome-like nanovesicles for improving tissue targeting and retention. Fundam Res. 2025;5(2):851-867. doi:10.1016/j.fmre.2024.03.025
Deng K, Chen Z, Zhang X, et al. Harnessing engineered exosomes for transformative therapy of cardiovascular and cerebrovascular disorders: Opportunities and challenges. Mater Des. 2025;256:114243. doi:10.1016/j.matdes.2025.114243
Serrano DR, Juste F, Anaya BJ, et al. Exosome-Based Drug Delivery: A Next-Generation Platform for Cancer, Infection, Neurological and Immunological Diseases, Gene Therapy and Regenerative Medicine. Pharmaceutics. 2025;17(10):1336. doi:10.3390/pharmaceutics17101336
Mendonca SR, Bangera PD, Keerikkadu M, Tippavajhala VK, Rathnanand M. Multifunctional Engineering of Exosomes for Precision Therapeutics: Strategies for Targeted Delivery, Barrier Evasion, and Clinical Translation. Pharm Res. 2025;42(11):1931-1952. doi:10.1007/s11095-025-03961-w
Zhou C, Zhang B, Yang Y, et al. Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing. Stem Cell Res Ther. 2023;14(1):107. doi:10.1186/s13287-023-03345-0
Arun M, Rajasingh S, Madasamy P, Rajasingh J. Immunomodulatory and Regenerative Functions of MSC-Derived Exosomes in Bone Repair. Bioengineering. 2025;12(8):844. doi:10.3390/bioengineering12080844
Foo JB, Looi QH, How CW, et al. Mesenchymal Stem Cell-Derived Exosomes and MicroRNAs in Cartilage Regeneration: Biogenesis, Efficacy, miRNA Enrichment and Delivery. Pharmaceuticals. 2021;14(11):1093. doi:10.3390/ph14111093
Li Q, Gao H, Ma X, Wang Z, Zhao L, Xiao W. Exosome‑mediated crosstalk between the cardiovascular and musculoskeletal systems: Mechanisms and therapeutic potential (Review). Int J Mol Med. 2025;56(3):1-23. doi:10.3892/ijmm.2025.5570
Xiao Y, Yuan Y, Hu D, Wang H. Exosome‐Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis. Batra L, ed. J Immunol Res. 2024;2024(1). doi:10.1155/2024/4481452
Chimal-Vega B, Maldonado-Arvizu JE, Hernández Avalos AD, Díaz-Villanueva JF, Avila-Barrientos LP, García González VG. Inter-Tissue Communication Mechanisms via Exosomes and Their Implications in Metabolic Diseases: Opportunities for Pharmacological Regulation. Futur Pharmacol. 2025;5(1):11. doi:10.3390/futurepharmacol5010011
Zhao G, Liu F, Liu Z, et al. MSC-derived exosomes attenuate cell death through suppressing AIF nucleus translocation and enhance cutaneous wound healing. Stem Cell Res Ther. 2020;11(1):174. doi:10.1186/s13287-020-01616-8
Chen J, Chen J, Cheng Y, et al. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation. Stem Cell Res Ther. 2020;11(1):97. doi:10.1186/s13287-020-01610-0
Li J, Huang Y, Sun H, Yang L. Mechanism of mesenchymal stem cells and exosomes in the treatment of age-related diseases. Front Immunol. 2023;14. doi:10.3389/fimmu.2023.1181308
Zhang Y, Zhang Y, Chopp M, Zhang ZG, Mahmood A, Xiong Y. Mesenchymal Stem Cell–Derived Exosomes Improve Functional Recovery in Rats After Traumatic Brain Injury: A Dose-Response and Therapeutic Window Study. Neurorehabil Neural Repair. 2020;34(7):616-626. doi:10.1177/1545968320926164
Jing S, Li H, Xu H. Mesenchymal Stem Cell Derived Exosomes Therapy in Diabetic Wound Repair. Int J Nanomedicine. 2023;Volume 18:2707-2720. doi:10.2147/IJN.S411562
Zubair M, Abouelnazar FA, Iqbal MA, et al. Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases. Front Cell Dev Biol. 2025;13. doi:10.3389/fcell.2025.1563427
Song Y, Zhang T, Shi P, Gao Y, Pang X. Exosomes derived from human amniotic mesenchymal stem cells promotes angiogenesis in hUVECs by delivering novel miRNA N-194. Mol Med. 2025;31(1):173. doi:10.1186/s10020-025-01192-8
Jian X, Han J, Liu X, et al. Exosome-carried miR-1248 from adipose-derived stem cells improves angiogenesis in diabetes-associated wounds. Int J Biol Macromol. 2025;297:139822. doi:10.1016/j.ijbiomac.2025.139822
Qu Q, Liu L, Wang L, et al. Exosomes derived from hypoxic mesenchymal stem cells restore ovarian function by enhancing angiogenesis. Stem Cell Res Ther. 2024;15(1):496. doi:10.1186/s13287-024-04111-6
Kang C, Han P, Lee JS, Lee D, Kim D. Anchor, Spacer, and Ligand-Modified Engineered Exosomes for Trackable Targeted Therapy. Bioconjug Chem. 2020;31(11):2541-2552. doi:10.1021/acs.bioconjchem.0c00483
Wang X, Soh KG, Samsudin S, et al. Effects of high-intensity training on jumping performance among athletes: a systematic review with meta-analysis. Sci Rep. 2025;15(1):1763. doi:10.1038/s41598-024-83161-5
Chen Y, Hou S. Targeted treatment of rat AKI induced by rhabdomyolysis using BMSC derived magnetic exosomes and its mechanism. Nanoscale Adv. 2024;6(16):4180-4195. doi:10.1039/D4NA00334A
Li JK, Yang C, Su Y, et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.684496
Thongboonkerd V. Roles for exosome in various kidney diseases and disorders. Front Pharmacol. 2020;10(January):1-14. doi:10.3389/fphar.2019.01655
Sepehri M, Rabbani S, Ai J, et al. Therapeutic potential of exosomes derived from human endometrial mesenchymal stem cells for heart tissue regeneration after myocardial infarction. Regen Ther. 2025;28:451-461. doi:10.1016/j.reth.2025.01.007
Zhu L, Zhang X, Yuan R, Chai Y. Y-shaped walker with abundant recognition domians mediated ultrasensitive electrochemical biosensor for miRNA-21 detection. Sensors Actuators B Chem. 2023;375:132901. doi:10.1016/j.snb.2022.132901
Chen Z, Xiong M, Tian J, Song D, Duan S, Zhang L. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review. J Nanobiotechnology. 2024;22(1):18. doi:10.1186/s12951-023-02259-6
de Abreu RC, Ramos C V., Becher C, et al. Exogenous loading of miRNAs into small extracellular vesicles. J Extracell Vesicles. 2021;10(10). doi:10.1002/jev2.12111
Tang L, Yang Y, Yang M, et al. miR-21-loaded bone marrow mesenchymal stem cell-derived exosomes inhibit pyroptosis by targeting MALT1 to repair chemotherapy-induced premature ovarian insufficiency. Cell Biol Toxicol. 2024;41(1):3. doi:10.1007/s10565-024-09946-6
Lv Q, Wang Y, Tian W, et al. Exosomal miR-146a-5p derived from human umbilical cord mesenchymal stem cells can alleviate antiphospholipid antibody-induced trophoblast injury and placental dysfunction by regulating the TRAF6/NF-κB axis. J Nanobiotechnology. 2023;21(1):419. doi:10.1186/s12951-023-02179-5
Wang T, Jian Z, Baskys A, et al. MSC-derived exosomes protect against oxidative stress-induced skin injury via adaptive regulation of the NRF2 defense system. Biomaterials. 2020;257:120264. doi:10.1016/j.biomaterials.2020.120264
Cao JY, Wang B, Tang TT, et al. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics. 2021;11(11):5248-5266. doi:10.7150/thno.54550
Huang J, Cao H, Cui B, et al. Mesenchymal Stem Cells-Derived Exosomes Ameliorate Ischemia/Reperfusion Induced Acute Kidney Injury in a Porcine Model. Front Cell Dev Biol. 2022;10(May):1-17. doi:10.3389/fcell.2022.899869
Ji X, Nie S, Li X, Liu H, Du X, Fan L. MSC ‐Derived Exosomal MiR‐127‐3p Alleviates Acute Kidney Ischemia–Reperfusion Injury via Suppressing ATG5 / ATG7 ‐Mediated Autophagy. Nephrology. 2025;30(6). doi:10.1111/nep.70054
He S, Wang Q, Chen L, He YJ, Wang X, Qu S. miR-100a-5p-enriched exosomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson’s disease model via regulation of Nox4/ROS/Nrf2 signaling. J Transl Med. 2023;21(1):747. doi:10.1186/s12967-023-04638-x
Ye J, Sun X, Jiang Q, et al. Umbilical cord blood-derived exosomes attenuate dopaminergic neuron damage of Parkinson’s disease mouse model. J Nanobiotechnology. 2024;22(1):567. doi:10.1186/s12951-024-02773-1
Butreddy A, Kommineni N, Dudhipala N. Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives. Nanomaterials. 2021;11(6):1481. doi:10.3390/nano11061481
Rezaie J, Feghhi M, Etemadi T. A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal. 2022;20(1):145. doi:10.1186/s12964-022-00959-4
Palakurthi SS, Shah B, Kapre S, et al. A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv. 2024;6(23):5803-5826. doi:10.1039/D4NA00501E
Wang Y, Zhu J, Ma Q, et al. Trends in mesenchymal stem cell-derived extracellular vesicles clinical trials 2014–2024: is efficacy optimal in a narrow dose range? Front Med. 2025;12. doi:10.3389/fmed.2025.1625787
Wang AYL, Kao HK, Liu YY, Loh CYY. Engineered extracellular vesicles derived from pluripotent stem cells: a cell-free approach to regenerative medicine. Burn Trauma. 2025;13. doi:10.1093/burnst/tkaf013
Zhao Y, Zhu X, Zhang L, et al. Mesenchymal Stem/Stromal Cells and their Extracellular Vesicle Progeny Decrease Injury in Poststenotic Swine Kidney Through Different Mechanisms. Stem Cells Dev. 2020;29(18):1190-1200. doi:10.1089/scd.2020.0030
Copyright (c) 2026 International Journal of Cell and Biomedical Science
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
